
Wanxiang Healthcare Investments
Overview
Corporate-backed venture group investing in healthcare technologies.
Founded
2016
Deals · 12mo
0
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Watershed Health | May 2024Participated | $14 MOther Equity | |
Carallel | Dec 2022Participated | $8 MSeries A | |
Circle | Jun 2022Participated | $6 MOther Equity | |
QbDVision | Feb 2022Participated | $15 MSeries A | |
Exo | Aug 2020Participated | $40 MSeries B | |
CareAcademy | Jun 2020Participated | $10 MSeries A | |
Augmedix | Oct 2019Participated | $19 MSeries B | |
Endotronix | Oct 2019Participated | $70 MSeries D | |
Exo | Aug 2019Participated | $35 MSeries B | |
Limelight Health | Jan 2019Participated | $34 MSeries C | |
Endotronix | Sep 2018Participated | $45 MSeries D | |
SchoolCare | Jan 2018Participated | $16 MSeries B | |
Watershed Health | May 2024Participated | $14 MOther Equity | |
Carallel | Dec 2022Participated | $8 MSeries A | |
Circle | Jun 2022Participated | $6 MOther Equity | |
QbDVision | Feb 2022Participated | $15 MSeries A | |
Exo | Aug 2020Participated | $40 MSeries B | |
CareAcademy | Jun 2020Participated | $10 MSeries A | |
Augmedix | Oct 2019Participated | $19 MSeries B | |
Endotronix | Oct 2019Participated | $70 MSeries D | |
Exo | Aug 2019Participated | $35 MSeries B | |
Limelight Health | Jan 2019Participated | $34 MSeries C | |
Endotronix | Sep 2018Participated | $45 MSeries D | |
SchoolCare | Jan 2018Participated | $16 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 5 |
| Series B | 0 | 5 |
| Series C+ | 0 | 3 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '17 | 1 |
| Mar '17 | 0 |
| Apr '17 | 1 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 1 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 1 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 1 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 1 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 1 |
| Sep '19 | 0 |
| Oct '19 | 2 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 1 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 14 |
| Networks, Cloud & Communication | 4 |
| Fintech | 3 |
| Education & Workforce | 2 |
| Enterprise Software | 2 |
| Manufacturing | 2 |
| Consumer & Lifestyle | 1 |
| Clean Energy & Sustainability | 1 |
| Data, Analytics & IT | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 4 |
| $10M-$25M | 5 |
| $25M-$50M | 4 |
| $50M-$100M | 1 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 15 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| 7wireVentures | 3 |
| MassMutual Ventures | 3 |
| 450 Ventures | 2 |
| Aperture Venture Partners | 2 |
| Applied Ventures | 2 |
| AXA Venture Partners | 2 |
| BioVentures Investors | 2 |
| Bold Capital | 2 |
| Create Health Ventures | 2 |
| Creative Ventures | 2 |
| FCA Venture Partners | 2 |
| Impact Engine | 2 |
| Intel Capital | 2 |
| Longevity Vision Fund | 2 |
| Lumira Ventures | 2 |
| Nautilus Venture Partners | 2 |
| OSF Healthcare | 2 |
| OSF Ventures | 2 |
| Rising Tide Fund | 2 |
| Seroba Life Sciences | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 15 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Founder & MD